Jonathan Siegal
Comptroller/Controller/Auditor chez VERICEL CORPORATION
Fortune : 72 828 $ au 31/03/2024
Profil
Jonathan D.
Siegal is currently working as the Chief Accounting Officer, VP & Controller at Vericel Corp.
Prior to his current position, he worked as the Global Controller at Lantheus Medical Imaging, Inc. from 2016 to 2021.
Mr. Siegal completed his undergraduate degree at Gordon College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERICEL CORPORATION
0,00% | 07/03/2024 | 1 400 ( 0,00% ) | 72 828 $ | 31/03/2024 |
Postes actifs de Jonathan Siegal
| Sociétés | Poste | Début |
|---|---|---|
| VERICEL CORPORATION | Comptroller/Controller/Auditor | - |
Anciens postes connus de Jonathan Siegal
| Sociétés | Poste | Fin |
|---|---|---|
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Comptroller/Controller/Auditor | 01/01/2021 |
Formation de Jonathan Siegal
| Gordon College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
